Picture of Zynex logo

ZYXIQ — Zynex News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapContrarian

Zynex Inc expected to post earnings of 8 cents a share - Earnings Preview

* Zynex Inc  ZYXI.OQ   ZYXI.O  is expected to show a rise in
quarterly revenue when it reports  results on July 25 for the
period ending June 30 2024
    * The Englewood Colorado-based  company is expected to
report a
15.9% increase in revenue to $52.093 million from $44.95 million
a year ago, according to the mean estimate from 3 analysts,
based on LSEG data.The company's guidance on April 30 2024, for
the period ended June 30, was for revenue of $52.000 million.
    * ​LSEG's mean analyst estimate for Zynex Inc is for
earnings of 8
cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Zynex Inc
is
$18.75​, above​ its last closing price of $10.15. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  LSEG IBES  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  ESTIMATE             MET,    SE %
               E®                               MISSED  
 Mar. 31 2024  0.03        0.03       0.00      Missed  -100
 Dec. 31 2024              0.17       0.21      Beat    23.5
 Jan. 1 0001   0.09        0.09       0.10      Beat    7.1​
 Jun. 30 2023  0.05        0.05       0.09      Beat    100
 ​​Mar.        0.02        0.01       0.04      Beat    200.1
 31 2023                                                
 Dec. 31 2022              0.19       0.20      Beat    6​
 Sep. 30 2022  0.12        0.12       0.13      Beat    7.4
 Jun. 30 2022  0.07        0.07       0.08      Beat    10.3
 This summary was machine generated July 23 at 20:13 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)

Recent news on Zynex

See all news